Mutant Bik gene transferred by cationic liposome inhibits peritoneal disseminated murine colon cancer

Clinical and Experimental Metastasis

Volumn 24, Issue 6, 2007, Pages 461-470

  Lan, Keng Li ^a   Yen, Sang Hue ^a,b   Liu, Ren Shyan ^a,b   Shih, How Ling ^a   Tseng, Fan Wei ^b   Lan, Keng Hsin ^a  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Apoptosis; BikDD; Bioluminescent imaging; Gene therapy; Liposome; Peritoneal carcinomatosis

Indexed keywords

LIPOSOME; RECOMBINANT DNA;

ANIMAL CELL; ARTICLE; BIK GENE; BIOLUMINESCENCE; COLON CANCER; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFECT; GENE TRANSFER; HUMAN; HUMAN CELL; IN VIVO STUDY; LIFESPAN; METASTASIS; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; NUCLEOTIDE SEQUENCE; PERITONEUM METASTASIS; TUMOR GROWTH; TUMOR VOLUME;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; APOPTOSIS; CATIONS; COLONIC NEOPLASMS; GENE THERAPY; LIPOSOMES; MICE; MITOCHONDRIAL PROTEINS; MUTATION; PERITONEAL NEOPLASMS; TRANSFECTION;

EID: 34548427008     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10585-007-9083-9     Document Type: Article

References (30)

1. Sugarbaker PH (2005) Strategies for the prevention and treatment of peritoneal carcinomatosis from gastrointestinal cancer. Cancer Invest 23(2):155-172
2. Oosterling SJ, van der Bij GJ, van Egmond M et al (2005) Surgical trauma and peritoneal recurrence of colorectal carcinoma. Eur J Surg Oncol 31(1):29-37
3. Vogel I, Kalthoff H (2001) Disseminated tumour cells. Their detection and significance for prognosis of gastrointestinal and pancreatic carcinomas. Virchows Arch 439(2):109-117
4. Zang RY, Shi DR, Lu HJ et al (2001) Adenovirus 5 E1a-mediated gene therapy for human ovarian cancer cells in vitro and in vivo. Int J Gynecol Cancer 11(1):18-23
5. Hortobagyi GN, Ueno NT, Xia W et al (2001) Cationic liposome-mediated E1A gene transfer to human breast and ovarian cancer cells and its biologic effects: a phase I clinical trial. J Clin Oncol 19(14):3422-3433
6. Hajri A, Wack S, Lehn P et al (2004) Combined suicide gene therapy for pancreatic peritoneal carcinomatosis using BGTC liposomes. Cancer Gene Ther 11(1):16-27
7. Kikuchi A, Aoki Y, Sugaya S et al (1999) Development of novel cationic liposomes for efficient gene transfer into peritoneal disseminated tumor. Hum Gene Ther 10(6):947-955
8. Yu HK, Ahn JH, Lee HJ et al (2005) Expression of human apolipoprotein(a) kringles in colon cancer cells suppresses angiogenesis-dependent tumor growth and peritoneal dissemination. J Gene Med 7(1):39-49
9. Reddy JA, Abburi C, Hofland H et al (2002) Folate-targeted, cationic liposome-mediated gene transfer into disseminated peritoneal tumors. Gene Ther 9(22):1542-1550
10. Lee MJ, Cho SS, You JR et al (2002) Intraperitoneal gene delivery mediated by a novel cationic liposome in a peritoneal disseminated ovarian cancer model. Gene Ther 9(13):859-866
11. Isayeva T, Ren C, Ponnazhagan S (2005) Recombinant adeno-associated virus 2-mediated antiangiogenic prevention in a mouse model of intraperitoneal ovarian cancer. Clin Cancer Res 11(3):1342-1347
12. Danial NN, Korsmeyer SJ (2004) Cell death: critical control points. Cell 116(2):205-219
13. Borner C (2003) The Bcl-2 protein family: sensors and checkpoints for life-or-death decisions. Mol Immunol 39(11):615-647
14. Papadopoulos K (2006) Targeting the Bcl-2 family in cancer therapy. Semin Oncol 33(4):449-456
15. Ghobrial IM, Witzig TE, Adjei AA (2005) Targeting apoptosis pathways in cancer therapy. CA Cancer J Clin 55(3):178-194
16. Yano J, Hirabayashi K, Nakagawa S et al (2004) Antitumor activity of small interfering RNA/cationic liposome complex in mouse models of cancer. Clin Cancer Res 10(22):7721-7726
17. Boyd JM, Gallo GJ, Elangovan B et al (1995) Bik, a novel death-inducing protein shares a distinct sequence motif with Bcl-2 family proteins and interacts with viral and cellular survival-promoting proteins. Oncogene 11(9):1921-1928
18. Han J, Sabbatini P, White E (1996) Induction of apoptosis by human Nbk/Bik, a BH3-containing protein that interacts with E1B 19K. Mol Cell Biol 16(10):5857-5864
19. Daniel PT, Pun KT, Ritschel S et al (1999) Expression of the death gene Bik/Nbk promotes sensitivity to drug- induced apoptosis in corticosteroid- resistant T-cell lymphoma and prevents tumor growth in severe combined immunodeficient mice. Blood 94(3):1100-1107
20. Zou Y, Peng H, Zhou B et al (2002) Systemic tumor suppression by the proapoptotic gene bik. Cancer Res 62(1):8-12
21. Verma S, Zhao LJ, Chinnadurai G (2001) Phosphorylation of the pro-apoptotic protein BIK: mapping of phosphorylation sites and effect on apoptosis. J Biol Chem 276(7):4671-4676
22. Li YM, Wen Y, Zhou BP et al (2003) Enhancement of Bik antitumor effect by Bik mutants. Cancer Res 63(22):7630-7633
23. Edinger M, Sweeney TJ, Tucker AA et al (1999) Noninvasive assessment of tumor cell proliferation in animal models. Neoplasia 1(4):303-310
24. Link KH, Sagban TA, Morschel M et al (2005)Colon cancer: survival after curative surgery. Langenbecks Arch Surg 390(2):83-93
25. Chen JS, Liu JC, Shen L et al (2004) Cancer-specific activation of the survivin promoter and its potential use in gene therapy. Cancer Gene Ther 11(11):740-747
26. Dow SW, Fradkin LG, Liggitt DH et al (1999) Lipid-DNA complexes induce potent activation of innate immune responses and antitumor activity when administered intravenously. J Immunol 163(3):1552-1561
27. Tousignant JD, Gates AL, Ingram LA et al (2000) Comprehensive analysis of the acute toxicities induced by systemic administration of cationic lipid:plasmid DNA complexes in mice. Hum Gene Ther 11(18):2493-2513
28. Loisel S, Le Gall C, Doucet L et al (2001) Contribution of plasmid DNA to hepatotoxicity after systemic administration of lipoplexes. Hum Gene Ther 12(6):685-696
29. Zhang JS, Liu F, Huang L (2005) Implications of pharmacokinetic behavior of lipoplex for its inflammatory toxicity. Adv Drug Deliv Rev 57(5):689-698
30. Lv H, Zhang S, Wang B et al (2006) Toxicity of cationic lipids and cationic polymers in gene delivery. J Control Release 114(1):100-109